@article{11070,
  keywords = {Humans, Cholesterol, LDL, *Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use, *Diabetes Mellitus, Type 2/complications/drug therapy/epidemiology, *Cardiovascular Diseases/drug therapy, Retrospective Studies, Cholesterol, *Atherosclerosis/complications/epidemiology, *Stroke/epidemiology/etiology, United Kingdom/epidemiology, Low-density lipoprotein cholesterol, Major adverse cardiovascular events, atherosclerotic cardiovascular disease, lipid-lowering therapy, Type 2 diabetes},
  author = {C. Morgan and A. Durand and T. McCormack and E. Hughes and T. Berni and R. Lahoz},
  title = {Risk of major adverse cardiovascular events associated with elevated low-density lipoprotein cholesterol in a population with atherosclerotic cardiovascular disease with and without type 2 diabetes: a UK database analysis using the CPRD},
  year = {2023},
  journal = {BMJ Open},
  volume = {13},
  edition = {2023/11/30},
  number = {11},
  pages = {e064541},
  isbn = {2044-6055},
  doi = {10.1136/bmjopen-2022-064541},
  note = {2044-6055
Morgan, Christopher Ll
Orcid: 0000-0001-8796-7406
Durand, Adeline
McCormack, Terry
Hughes, Elizabeth
Berni, Thomas R
Lahoz, Raquel
Journal Article
England
BMJ Open. 2023 Nov 29;13(11):e064541. doi: 10.1136/bmjopen-2022-064541.},
  language = {eng},
}